These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. [Acid phosphatase of leukocytes in patients with diffuse toxic goiter in evaluating the stage of the disease]. Vaiuta NP; Livshits AKh; Mendeleev IM Ter Arkh; 1987; 59(6):104-6. PubMed ID: 3629485 [TBL] [Abstract][Full Text] [Related]
23. [Radioisotope methods of control of the effectiveness of treatment of diffuse toxic goiter with mercazolyl]. Egorenkov AN Med Radiol (Mosk); 1976; 21(9):47-53. PubMed ID: 1036752 [No Abstract] [Full Text] [Related]
24. Serum thyroglobulin level in patients with diffuse and nodular goiter, after therapeutic application of stable iodine. Djurica SN; Cirović M; Tasovac-Ponomarev D Exp Clin Endocrinol; 1992; 99(1):21-5. PubMed ID: 1628693 [TBL] [Abstract][Full Text] [Related]
25. The prevalence of elevated serum C-reactive protein levels in inflammatory and noninflammatory thyroid disease. Pearce EN; Bogazzi F; Martino E; Brogioni S; Pardini E; Pellegrini G; Parkes AB; Lazarus JH; Pinchera A; Braverman LE Thyroid; 2003 Jul; 13(7):643-8. PubMed ID: 12964969 [TBL] [Abstract][Full Text] [Related]
26. [Effect of thyrostatic therapy on various immunologic indices in patients with diffuse toxic goiter]. Vnotchenko SL; Starkova NT; Mkrtumova NA Probl Endokrinol (Mosk); 1983; 29(4):19-23. PubMed ID: 6604271 [TBL] [Abstract][Full Text] [Related]
27. [Treatment of diffuse toxic goiter with radioactive iodine in combination with prolonged antithyroid therapy]. Khramtsova VIa; Potin VV; Shliakhtina LG Probl Endokrinol (Mosk); 1977; 23(2):48-51. PubMed ID: 71726 [TBL] [Abstract][Full Text] [Related]
28. Monitoring and Evaluation of Thyroid Function Tests, Serum Electrolytes and Creatinine Levels Before and After 131I Therapy. Mehmood R; Khan MS; Hussain S; Ahmed A; Arshad FA; Mukhtar R Endocr Metab Immune Disord Drug Targets; 2020; 20(3):419-424. PubMed ID: 31465286 [TBL] [Abstract][Full Text] [Related]
30. [Correlation between serum thyroglobulin and thyroid stimulating hormone in populations with non-toxic goiter]. Hu FN; Jin Y; Teng WP; Yang F; Teng XC; Gao TS; Wang WB; Shi XG; Tao CM Zhonghua Yi Xue Za Zhi; 2003 Jun; 83(11):936-9. PubMed ID: 12899791 [TBL] [Abstract][Full Text] [Related]
31. [Lipids of blood and erythrocyte membranes in healthy persons and in patients with diffuse toxic goiter, residing in the European North of the USSR]. Shatsova EN; Danilova RI; Zazhigina RN Ter Arkh; 1988; 60(9):47-50. PubMed ID: 3217880 [TBL] [Abstract][Full Text] [Related]
32. [Vitamin E and malondialdehyde in the blood serum of thyrotoxicosis patients]. Danis IuK; Marchiulënite DIu; Danite EIu; Cherniauskene RCh Probl Endokrinol (Mosk); 1990; 36(5):21-4. PubMed ID: 2080138 [TBL] [Abstract][Full Text] [Related]
33. [Clinical peculiarities of diffuse toxic goiter in males]. Romanchishen AF; Volert VA Vestn Khir Im I I Grek; 2005; 164(6):43-7. PubMed ID: 16792314 [TBL] [Abstract][Full Text] [Related]
34. [Different etiology of thyrotoxicosis as a function of previous prevalence of goiter]. Cordido F; Vidal JI; Valiño D; Tuñez F; Maíz D; Jorge S; Vidal O Med Clin (Barc); 1992 Jun; 99(5):175-8. PubMed ID: 1507896 [TBL] [Abstract][Full Text] [Related]
35. [Iodine-induced hyperthyroidism (iodine-induced Basedow's disease): a current disease picture]. Henzen C; Buess M; Brander L Schweiz Med Wochenschr; 1999 May; 129(17):658-64. PubMed ID: 10407936 [TBL] [Abstract][Full Text] [Related]
36. Thyroid function in Japanese adults as assessed by a general health checkup system in relation with thyroid-related antibodies and other clinical parameters. Kasagi K; Takahashi N; Inoue G; Honda T; Kawachi Y; Izumi Y Thyroid; 2009 Sep; 19(9):937-44. PubMed ID: 19678737 [TBL] [Abstract][Full Text] [Related]
37. [Features of osteopenic syndrome in diffuse toxic goiter]. Nekrasova MR; Suplotova LA; Davydova LI Ter Arkh; 2005; 77(10):29-33. PubMed ID: 16320681 [TBL] [Abstract][Full Text] [Related]
38. Detectability of thyroid anti-microsomal antibodies, changes in thyroid-stimulating immunoglobulins (TSI) and thyrotropin-binding-inhibiting immunoglobulins (TBII) during methimazole treatment of Graves' disease patients. Szabó J; Leövey A; Karányi Z; Várvölgyi C; Fórizs E; Herceg L Acta Med Hung; 1989; 46(1):23-30. PubMed ID: 2570399 [TBL] [Abstract][Full Text] [Related]
39. [Thyroliberin test after treatment of thyrotoxicosis]. Vakulenko AD Probl Endokrinol (Mosk); 1984; 30(1):16-21. PubMed ID: 6424107 [TBL] [Abstract][Full Text] [Related]
40. Autoimmune hyperthyroidism occurring late after radioiodine treatment for volume reduction of large multinodular goiters. Huysmans AK; Hermus RM; Edelbroek MA; Tjabbes T; Oostdijk ; Ross HA; Corstens FH; Kloppenborg PW Thyroid; 1997 Aug; 7(4):535-9. PubMed ID: 9292939 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]